1. Al-Madani W, Ahmed AE, Arabi H, et al. (2019): Modelling risk assessment for cervical cancer in symptomatic Saudi women. Saudi Med J 40: 447-451.
2.
Zhao Y, Wu K, Tong H, et al. (2018): Genotype patterns and prevalence of human papilloma virus in non-vaccinated women in Zunyi, China. Saudi Med J 39: 572-578.
3.
Zigras T, Lennox G, Willows K, et al. (2017): Early cervical cancer: Current dilemmas of staging and surgery. Curr Oncol Rep 19: 51.
4.
Ding J, Zhang L, Zeng S, et al. (2019): Clinically relevant concentration of Sevoflurane suppresses cervical cancer growth and migration through targeting multiple oncogenic pathways. Biochem Biophys Res Commun 514: 1179-1184.
5.
Xue F, Xu Y, Song Y, et al. (2019): The effects of sevoflurane on the progression and cisplatinum sensitivity of cervical cancer cells. Drug Des Devel Ther 13: 3919-3928.
6.
Zhang W, Sheng B, Chen S, et al. (2020): Sevoflurane enhances proliferation, metastatic potential of cervical cancer cells via the histone deacetylase 6 modulation in vitro. Anesthesiology 132: 1469-1481.
7.
He J, Zhao H, Liu X, et al. (2020): Sevoflurane suppresses cell viability and invasion and promotes cell apoptosis in colon cancer by modulating exosome-mediated circ-HMGCS1 via the miR-34a-5p/SGPP1 axis. Oncol Rep 44: 2429-2442.
8.
Wang D, Lin Y, Xu F, et al. (2022): SIRP maintains macrophage homeostasis by interacting with PTK2B kinase in Mycobacterium tuberculosis infection and through autophagy and necroptosis. EBioMedicine 85: 104278.
9.
Han C, Deng Y, Xu W, et al. (2022): The roles of tumor-associated macrophages in prostate cancer. J Oncol 2022: 8580043.
10.
Berchuck JE, Viscuse PV, Beltran H, et al. (2021): Clinical considerations for the management of androgen indifferent prostate cancer. Prostate Cancer Prostatic Dis 24: 623-637.
11.
Lou JS, Yan L, Bi CW, et al. (2016): Yu Ping Feng San reverses cisplatin-induced multi-drug resistance in lung cancer cells via regulating drug transporters and p62/TRAF6 signalling. Sci Rep 6: 31926.
12.
Zhang J, Jiang P, Wang S, et al. (2021): LncRNA LIPE-AS1 predicts poor survival of cervical cancer and promotes its proliferation and migration via modulating miR-195-5p/MAPK pathway. Front Oncol 11: 639980.
13.
Liu ZX, Li LM, Sun HL, et al. (2018): Link between m6A modification and cancers. Front Bioeng Biotechnol 6: 89.
14.
Zhang L, Cheng Y, Xue Z, et al. (2022): Sevoflurane impairs m6A-mediated mRNA translation and leads to fine motor and cognitive deficits. Cell Biol Toxicol 38: 347-369.
15.
Sun X, Li Q, Yang L (2022): Sevoflurane inhibits lncRNA HOTAIR-modulated stability of HK2 mRNA in a m6A-dependent manner to dampen aerobic glycolysis and proliferation in lung cancer. Biomed Res Int 2022: 4668774.
16.
Justus CR, Leffler N, Ruiz-Echevarria M, et al. (2014). In vitro cell migration and invasion assays. J Vis Exp 88: 51046.
17.
Zhou Y, Zhou B, Pache L, et al. (2019): Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun 10: 1523.
18.
Dominissini D, Moshitch-Moshkovitz S, Salmon-Divon M, et al. (2013): Transcriptome-wide mapping of N(6)-methyladenosine by m(6)A-seq based on immunocapturing and massively parallel sequencing. Nat Protoc 8: 176-189.
19.
Li H, Li Y, Ao H, et al. (2018): Folate-targeting annonaceous acetogenins nanosuspensions: significantly enhanced antitumor efficacy in HeLa tumor-bearing mice. Drug Deliv 25: 880-887.
20.
Iwasaki M, Zhao H, Hu C, et al. (2023): The differential cancer growth associated with anaesthetics in a cancer xenograft model of mice: mechanisms and implications of postoperative cancer recurrence. Cell Biol Toxicol 39: 1561-1575.
21.
Uchida Y, Chiba T, Kurimoto R, et al. (2019): Post-transcriptional regulation of inflammation by RNA-binding proteins via cis-elements of mRNAs. J Biochem 166: 375-382.
22.
Ma S, Chen C, Ji X, et al. (2019): The interplay between m6A RNA methylation and noncoding RNA in cancer. J Hematol Oncol 12: 121.
23.
Zhou Y, Zeng P, Li YH, et al. (2016): SRAMP: prediction of mammalian N6-methyladenosine (m6A) sites based on sequence-derived features. Nucleic Acids Res 44: e91.
24.
Sztwiertnia I, Schenz J, Bomans K, et al. (2020). Sevoflurane depletes macrophages from the melanoma microenvironment. PLoS One 15: e0233789.
25.
Wang JN, Wang F, Ke J, et al. (2022): Inhibition of METTL3 attenuates renal injury and inflammation by alleviating TAB3 m6A modifications via IGF2BP2-dependent mechanisms. Sci Transl Med 14: eabk2709.
26.
Mauer J, Luo X, Blanjoie A, et al. (2017): Reversible methylation of m6Am in the 5’ cap controls mRNA stability. Nature 541: 371-375.
27.
Bayoumi M, Munir M (2021): Evolutionary conservation of the DRACH signatures of potential N6-methyladenosine (m6A) sites among influenza A viruses. Sci Rep 11: 4548.
28.
Masuda J, Shigehiro T, Matsumoto T, et al. (2018): Cytokine expression and macrophage localization in xenograft and allograft tumor models stimulated with lipopolysaccharide. Int J Mol Sci 19: 1261.
29.
Yuan J, Fei Y (2022): Lidocaine ameliorates chronic constriction injury-induced neuropathic pain through regulating M1/M2 microglia polarization. Open Med (Wars) 17: 897-906.
30.
Liu Z, Meng Y, Miao Y, et al. (2021): Propofol ameliorates renal ischemia/reperfusion injury by enhancing macrophage M2 polarization through PPARγ/STAT3 signaling. Aging 13: 15511-15522.